Epidermal growth factor (EGF) increases the renal amino acid transport capacity in amino acid loaded rats.
In anaesthetized adult female rats, the influence of epidermal growth factor (EGF) on renal amino acid handling was investigated in glutamine, arginine (both 50 mg/100 g b.wt. per hour), or alanine (90 mg/100 g b.wt. per hour) loaded animals. Continuous infusions of the three amino acids were followed by an increase in the fractional excretion (FE) of the administered amino acids as well as of the other endogenous amino acids. Under load conditions (alanine, arginine or glutamine), EGF pretreatment (8 micrograms/100 g b.wt. subcutaneously for 8 days, twice daily 8 a.m. and 4 p.m.) was followed by a stimulation of renal amino acid reabsorption. The increase in the fractional excretion of the administered amino acids was significantly lower than in non-EGF-treated rats. These changes in amino acid transport were connected with a significant reduction of GFR after EGF pretreatment (0.96 +/- 0.10 vs. 0.62 +/- 0.07 ml/min x 100 g b.wt.) and a distinct increase in sodium excretion (2.98 +/- 0.55 vs. 4.97 +/- 0.71 muval/100 g b.wt. x 20 min). After loading with p-aminohippurate (PAH; 200 mg/100 g b.wt.), PAH excretion in EGF rats was increased by about 20%, whereas urinary protein excretion was lower in EGF pretreated rats (control: 0.45 +/- 0.04 vs. EGF: 0.18 +/- 0.03 mg/100 g b.wt. x 20 min). The PAH load reduced amino acid reabsorption as a sign of overloading of renal tubular transport capacity, but in EGF pretreated animals the amino acid excretion was only slightly increased under these conditions. Furthermore, EGF pretreatment depressed normal kidney weight gain significantly (874 +/- 18 vs. 775 +/- 32 mg/100 g b.wt.). EGF can improve the renal tubular transport capacity, but, compared to well-known stimulators of renal transport like dexamethasone or triiodothyronine, its effect is only of a moderate degree.
Fleck
C
C
Institute of Pharmacology and Toxicology, Friedrich Schiller University of Jena, Federal Republic of Germany. CFLE@mti-n.uni-jena.de
Pertsch
J
J
D000409:Alanine / Q000097:blood / Q000494:pharmacology / Q000652:urine; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D001120:Arginine / Q000097:blood / Q000494:pharmacology / Q000652:urine; D001692:Biological Transport; D004815:Epidermal Growth Factor / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D005260:Female; D005973:Glutamine / Q000097:blood / Q000494:pharmacology / Q000652:urine; D007328:Insulin / Q000097:blood / Q000652:urine; D007668:Kidney / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D010130:p-Aminohippuric Acid / Q000494:pharmacology
D000596:Amino Acids; D007328:Insulin; D005973:Glutamine; D004815:Epidermal Growth Factor; D001120:Arginine; D000409:Alanine; D010130:p-Aminohippuric Acid